Hu ZP et al36 found that circulating plasma concentrations of SFRP5 were decreased in T2DM patients compared with healthy controls and they were negatively correlated with homeostasis model assessment of insulin resistance, suggesting that SFRP5 might exert a protective effect on the mechanism of T2DM. The gene discussed is SFRP5; the disease is Insulin resistance.